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POPULAR SCIENCE SUMMARY OF THE THESIS 
The mammalian brain and spinal cord are particularly inefficient at repairing themselves after 
injury. A traumatic lesion to the brain can lead to extensive death of neurons, which are never 
replaced. The poor regenerative capacity of these cells is at the basis of the lifelong neurological 
symptoms seen in patients who suffered brain damage. Thus, the ultimate objective of 
regenerative medicine approaches is to promote replacement of the cells lost to injury in order 
to aid recovery of function. Several sources for neuronal cell replacement are currently being 
explored. Transplantation of cells derived from external sources is showing promising results 
in pre-clinical settings and is now being tested in patients. This approach, however, comes with 
risks and warrants research towards attempting to recruit and repurpose cells that are already 
found in the injured brain. Small populations of neural stem cells that generate new neurons 
throughout life do exist, but their restricted population size limits the extent to which these cells 
can be utilized for replacing vast number of lost neurons. Astrocytes represent an attractive 
alternative for the generation of new neurons after injury because they are abundantly found 
throughout the brain and share several molecular and functional characteristics with adult 
neural stem cells. Work presented in this thesis aims at demonstrating that astrocytes can be 
considered as a latent source of neural stem cells, which can be recruited under the right 
conditions to replace lost neurons. We, furthermore, provide extensive characterization of 
neural stem cells and their progeny (i.e., neural progenitors and immature neurons) from the 
human brain, which will, in the future, represent a valuable resource to identify what cellular 





The mammalian central nervous system has limited regenerative capacity and the long-lasting 
functional impairment resulting from trauma and neurodegenerative disease derives from a 
failure to repopulate neuronal cell populations that are lost to injury. The studies included in 
the present thesis aim at proposing astrocytes as a novel source for achieving widespread 
replacement of neurons. Central to this work are notions within the field of astrocyte biology, 
adult neurogenesis, and regenerative medicine, which are discussed in the literature review.  
Astrocytes are an abundant cell population that supports neuronal development, survival and 
activity in health and participate in inflammation and injury resolution in disease. Learning 
about astrocyte biology allows us to develop tools for selectively targeting these cells or their 
specific functions. It will also help us learn about heterogeneous subtypes with distinctive 
functional properties or differential potential for regenerative repair.  
Adult neurogenesis is the process through which new neurons are added throughout life to a 
pre-existing neural circuitry. This process has been extensively explored in model organisms, 
but it has been challenging to achieve the same level of resolution and detail for the study of 
human neurogenesis. It is nevertheless important to identify and characterize neurogenic cells 
in the human brain and investigate their functional impact on cognition, as well as how their 
dysregulation may be linked to neurodegenerative and psychiatric diseases. In the context of 
this thesis, learning about the molecular dynamics driving neurogenesis allowed us to 
demonstrate that astrocytes, once recruited, unfold a process of differentiation like that seen in 
neural stem cells (Paper I and Paper II). We, furthermore, profiled the transcriptome of young 
and adult human hippocampal cells and depicted, for the first time, a comprehensive molecular 
framework that describes the neurogenic program in the human dentate gyrus (Paper III). 
Cell replacement therapies are obtaining promising results in pre-clinical settings and are 
starting to be successfully used in patients to replace specific cell populations depleted due to 
neurodegeneration or injury. The present thesis discusses the two main strategies to approach 
cell replacement, namely transplantation and recruitment of endogenous cells with stem cell 
properties. The latter has gained momentum in recent years to overcome limitations 
characteristic of cell transplantation. Work within this thesis is aimed in this direction and 
provides evidence that parenchymal astrocytes can be considered latent neural stem cells and 
can be recruited to replace neurons after injury (Paper I and Paper II). 
From the methodological point of view, genomics technologies and computational approaches 
are important concepts to this thesis and have been applied, here, to study canonical and 
reactive neurogenesis. Published single-cell omics data across organs, developmental times, 
and species have enabled comprehensive investigations of cell processes and interactions that 
had remained until now elusive. Here, we leveraged transcriptome-wide analysis to investigate 
the molecular dynamics underlying astrocyte-mediated neurogenesis in the striatum (Paper I) 
and the cortex (Paper II), and to study human hippocampal neurogenesis with an unparalleled 
 
 
level of detail, which we used to identify markers of neural progenitors and to compare 
molecular processes across species (Paper III). 
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The mammalian central nervous system has limited regenerative capacity following injury, and 
damage can lead to functional impairment that is never fully overcome. Populations of 
specialized astrocytes that act as adult neural stem cells exist in specific regions of the 
mammalian brain, where they contribute to lifelong addition of new neurons, through a process 
called adult neurogenesis (Doetsch et al., 1999; Kriegstein and Alvarez-Buylla, 2009). These 
cells can also respond to injury by increasing their proliferation and migrating towards sites of 
damage (Arvidsson et al., 2002; Gotts and Chesselet, 2005; Kaneko et al., 2018; Yan et al., 
2018). Their contribution to regenerative repair is, however, very limited due to their small 
population size. Parenchymal astrocytes, on the other hand, make up about half of all neural 
cells and they are found throughout the brain and spinal cord. Our studies in Paper I and Paper 
II have shown that parenchymal astrocytes may act as latent neural stem cells whose 
neurogenic potential can be unlocked following injury or through genetic manipulation of 
signaling pathways known to be implicated in neuronal cell fate specification. Our work 
suggests that astrocytes may be a valuable endogenous resource for replacing neurons lost to 
injury and that learning the molecular profiles of astrocytes committed to the lineage transition 
can help us harness a greater regenerative potential. The present thesis discusses the importance 
of astrocyte biology in health and disease, and it goes on to explore the body of research 
pertaining to adult neurogenesis. Finally, it reviews current strategies to leverage our 
knowledge in the field of astrocyte and neural stem cell biology in order to promote 
regenerative repair in the injured brain.  
Astrocytes undertake a wide range of functions in the intact brain that ensure wellbeing and 
correct activity of neuronal cells (Barres, 2008). Interestingly, there is accumulating evidence 
suggesting that, similar to the diverse collection of neuronal subtypes, astrocytes, too, are a 
widely heterogeneous population (Bayraktar et al., 2020; Khakh and Deneen, 2019). This raises 
questions of whether all astrocytes are equally capable of displaying the full repertoire of glial 
functions. Particularly relevant for the present research, is the question of whether all astrocytes 
retain the potential to generate neurons. Interestingly, we have detected some differences in the 
stimuli required to activate the neurogenic program between subcortical (Paper I) and cortical 
astrocytes (Paper II). Nevertheless, we were able to demonstrate a widespread potential to 
generate neurons, which is preserved in astrocytes from different cortical regions, as well as 
throughout the cortical layers (Paper II). Astrocytes also partake during injury and disease 
where they undergo morphological changes and gain functions of reactive cells (Sofroniew, 
2020). In the context of traumatic injury, astrocytes proliferate and contribute to the formation 
of a scar to contain damage (Wahane and Sofroniew, 2021). Other aspects of gliosis are, 
instead, displayed in infections and neurodegenerative diseases, such as the release of 
neurotoxins that kill the neighboring neurons (Guttenplan et al., 2021; Liddelow et al., 2017). 
Our analysis explored the molecular profiles of astrocytes as they commit to the neuronal 
lineage fate and revealed that neurogenesis in the injured cortex unfolds independently of 
reactive gliosis (Paper II). Astrocytes that display reactive morphological and transcriptional 
 
2 
changes are, in fact, rarely associated with the activation of pro-neuronal transcription factors, 
which suggests that the neurogenic program may be hindered in this cell state. 
Neural stem cells are specialized astrocytes  (Kriegstein and Alvarez-Buylla, 2009) that exist 
throughout life but are restricted to two small regions of the mammalian brain, namely the 
subventricular zone and the dentate gyrus of the hippocampus (Gould, 2007). Stem cells in the 
subventricular zone give rise to migratory neural progenitors that innervate distinct regions in 
different mammalian species. Mouse neuroblasts, for instance, target the olfactory bulb 
(Belluzzi et al., 2003), whereas human neuroblasts mature into striatal interneurons (Ernst et 
al., 2014). The lower reliance of humans on olfaction may explain why neuroblasts have been 
redirected to the striatum, a region of the brain important for movement coordination, but also 
higher cognitive functions and affection regulation. In the hippocampus, adult-born granule 
neurons that are added to the dentate gyrus are crucial for memory formation and learning 
(Akers et al., 2014; Clelland et al., 2009). Although adult hippocampal neurogenesis has been 
shown across mammalian species, and their occurrence in humans validated using several 
independent measurements, a recent study has raised controversy proposing that human 
neurogenesis would not endure into adulthood (Sorrells et al., 2018). Demonstration of 
neurogenesis relied on the ability to detect specific marker proteins expressed in immature 
neurons. These proteins are, however, quickly degraded with increasing postmortem delay and 
protocols used to visualize them can be complex, particularly when using specimens from adult 
brains (Kempermann et al., 2018). Thus, failure of this study to demonstrate the presence of 
neuroblasts rather reflects the technical challenges characteristic of working with human 
postmortem tissue and expresses the need for finding additional ways to follow the addition of 
new neurons to the hippocampus. In Paper III, we used single-nucleus RNA-sequencing 
(snRNA-seq) to profile cells of the human dentate gyrus across ages and provided an in-depth 
characterization of the neurogenic trajectory. Furthermore, we compared neurogenic programs 
between human and mouse, to learn the extent to which the molecular profiles of neural 
progenitors overlap. Our study will provide a resource for better understanding the 
differentiation trajectory of human neural stem cells and expand the collections of cell type 
markers to detect the presence of neurogenic cells in the human brain. Importantly, 
transcriptomics analysis offers a more complete molecular framework that characterize neural 
stem cells and their lineage commitment. This, in turn, may allow us to identify potential 
regulators of neurogenesis that could be targeted to unlock the neurogenic potential of 
facultative stem cells, such as parenchymal astrocytes, to promote regeneration in widespread 
areas of the brain after injury. 
Brain injuries and neurodegenerative diseases display complex and distinct pathophysiological 
profiles but tend to share aspects of neuronal death that are at the basis of their long-lasting 
functional impairment. Efforts of regenerative medicine are aimed at replacing cells lost to 
injury in the hope to achieve recovery of function. Two main strategies are explored towards 
this end, namely the replacement of neurons through cell transplantation and recruitment of 
resident cells with regenerative potential. Transplantation approaches have proven promising 
and are currently being explored in clinical trials (Parmar et al., 2020). There are, however, 
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limitations and risks associated with these therapies, which have encouraged efforts towards 
trying to harness the regenerative potential of endogenous cells (Parmar et al., 2020). Our work 
in Paper I and Paper II moves in this direction, proposing that astrocytes may be a valuable 
alternative source of latent stem cells that can generate new neurons in the injured brain. 
Strategies that leverage endogenous sources for cell replacement overcome some of the 
shortcomings of cell transplantation, but there is still a lot of work to be done to (1) improve 
efficiency of the conversion from the original cell; (2) demonstrate integration of the newly 
generated neurons and functional impact of their contribution; and (3) develop safe and 
effective therapeutic strategies to recruit the latent stem cells into regenerative programs. 
Single-cell transcriptomic analysis can be leveraged to explore the molecular dynamics driving 
lineage fate switch and instruct search for regulators of this phenomenon (Kamimoto et al., 
2020). Particularly interesting, in this sense, is the study of cells that fail to turn on the 
neurogenic program, and comparing these to successfully activated cells can help identifying 
factors we can target to achieve greater recruitment. In Paper I, we show that many striatal 
astrocytes initiate upregulation of pro-neuronal programs but fail to commit to the transition 
before entering cell division. Forcing cells into the cell cycle was, however, sufficient to allow 
them to complete the transition. Gene editing tools, such as the CRISPR-Cas9 system, and 
virus-mediated delivery of genetic material hold great promises for the development of 
therapeutic strategies to achieve specific and efficient gene expression manipulation (Dahlman 
et al., 2015; Zhou et al., 2018). To promote replacement of neurons lost to injury, these 
technologies can be adapted to drive expression of the regulators of cell fate switch (Liu et al., 
2018; Russo et al., 2021), in order to activate regenerative programs in larger numbers of 





2 ASTROCYTES IN HEALTH AND DISEASE 
 
“What could hold these tiny, isolated, flexible, very delicate cells, much more 
delicate and smaller than the nerve cells?”  
¾ Ramón y Cajal, 1895 
 
The neuroscience community has made enormous progress at characterizing the wide range of 
physiological functions undertaken by astrocytes in the central nervous system. Originally 
described as a rather inert, uninteresting cell type that keeps the brain together structurally, as 
the term ‘glia’ (from Greek, “glue”), coined by Virchow in 1856, implies, we have now learned 
that astrocytes are instrumental for survival and correct functioning of the neighboring neurons 
(Barres, 2008). Early investigations have demonstrated their trophic support of neurons when 
cultured together (Banker, 1980). Since then, they have also been implicated in synaptic 
transmission via uptake of glutamate from the synaptic cleft and maintenance of ionic balance, 
which tunes the neurons’ membrane potential (Seifert et al., 2018; Verkhratsky and 
Nedergaard, 2018; Verkhratsky et al., 2020). Furthermore, they actively participate in neuronal 
communication, responding to synaptic activity through alterations in cytosolic calcium 
concentrations  (Fischer et al., 2020; Verkhratsky et al., 2012) and release of gliotransmitters 
to signal neighboring neurons (Araque et al., 2014). Astrocytes are also crucial, during 
development, for the establishment of connections by providing molecular cues, such as 
thrombospondins, that drive synaptogenesis, as well as instructing axonal growth and path 
finding via secretion of cytokines (Molofsky et al., 2012). The dynamic regulation of synaptic 
connectivity, as well as the ability of specialized astrocytes to generate new neurons, is retained 
in the adult brain where they contribute, for instance, to hippocampal plasticity (Harris et al., 
2021; Lee et al., 2021). With their end-feet enwrapping blood vessels (Foo et al., 2011), 
astrocytes are also known for regulating blood flow (Beiersdorfer et al., 2019; Otsu et al., 2015) 
and establishing the blood-brain barrier, which ultimately contributes to a finely regulated 
metabolic and ionic supply to the parenchymal environment (Abbott et al., 2006). Considering 
the wide range of astroglial functions that support neurons, it is perhaps not surprising that 
malfunctioning or reactive astrocytes may also have the power to trigger neurotoxicity and 
neurodegeneration (Liddelow and Sofroniew, 2019). For instance, astrocytes carrying a mutant 
form of SOD1, a gene linked to amyotrophic lateral sclerosis, are directly responsible for the 
degeneration of motor neurons (Di Giorgio et al., 2007; Nagai et al., 2007). Similarly, chimeric 
mice harboring human glia with Huntingtin mutations have shown that mutant astrocytes alone 
can impart behavioral phenotypes typical of the disease, whereas healthy glia are able to rescue 
Huntington’s symptoms in diseased mice (Benraiss et al., 2016). As described later on in this 
thesis, astrocytes that participate in the context of injury change their molecular and structural 
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profiles (Sofroniew, 2020) and may contribute to either inflammation and neuronal death or to 
repair, in a context-dependent manner (Hasel et al., 2021; Zamanian et al., 2012).  
2.1 ASTROCYTE HETEROGENEITY 
Appreciation of the wide range of astroglial functions has raised questions around the extent to 
which these are shared among astrocytes throughout the central nervous system. Are all 
astrocytes displaying the same functions? Or are there spatiotemporal differences in their 
commitment to brain physiology? For instance, there may exist regionally specialized glia 
whose functions are tailored to supporting specific subtypes of neurons (Kelley et al., 2018; 
Lanjakornsiripan et al., 2018). Additionally, within each region, astrocytes may be found in 
contact with, or separated from blood vessels (Foo et al., 2011). The so called juxtavascular 
astrocytes, with their cell body adjacent to blood vessels, originate from a pool of progenitors 
that is distinct from that of non-juxtavascular astrocytes (Bribian et al., 2016; Figueres-Onate 
et al., 2016) and present unique molecular and electrophysiological properties in the intact and 
injured brains (Gotz et al., 2021). Interestingly, even though they only make up 30% of the 
total parenchymal astrocytes, they are the major contributors of proliferating astrocytes 
(Bardehle et al., 2013; Frik et al., 2018; Sirko et al., 2013). Astroglial functions can also differ 
based on developmental time (Cahoy et al., 2008). Secretion of thrombospondins and 
semaforins, for example, are crucial for synaptogenesis and axon guidance during 
development, but they lose relevance as the neural circuit becomes established (Allen and 
Eroglu, 2017; Christopherson et al., 2005). Importantly, there also exist a subtype of specialized 
astrocytes that function as adult neural stem cells and generate new neurons that are added to 
the brain throughout the lifespan. This subtype of glia is discussed more extensively later in 
this thesis, in the context of adult neurogenesis. 
The existence of heterogeneous subtypes within the astrocyte population has been postulated 
since the seminal work of Ramon y Cajal, who recorded morphological differences of 
astrocytes across brain structures (Navarrete and Araque, 2014). These differences are, for 
instance, evident between white and gray matter astrocytes, where glia present fibrous 
morphologies with few well-defined processes, or a ‘bushy’ appearance with numerous small 
processes, typical of protoplasmic astrocytes in the gray matter (Kettenmann and Verkhratsky, 
2008). Further differences in morphologies are readily observable in the human brain, where 
gray matter astrocytes also encompass layer I intralaminar and layer V-VI polarized astrocyte 
subpopulations (Oberheim et al., 2006). Recently, systematic investigations have revealed 
more minute morphological differences among astrocytes from different cortical and 
subcortical regions (Lanjakornsiripan et al., 2018; Minge et al., 2021), as well as distinct 
developmental times (Minge et al., 2021). Paralleling these morphological aspects are also 
differences in the molecular profiles of astrocyte subtypes spanning the layers of the neocortex 
(Batiuk et al., 2020; Bayraktar et al., 2020), as well as region-specific differences in 
transcription factor expression profiles (Huang et al., 2020; Lozzi et al., 2020). Original 
investigations of astrocyte heterogeneity could report about distinctive morphological and 
molecular features, but it has been challenging to demonstrate that these phenotypes are 
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associated with heterogeneity of function. However, recent investigations are beginning to 
tackle the question of whether there exist functionally distinct subpopulations of glia. For 
instance, spinal cord astrocytes associated with a subtype of motor neurons express distinct 
levels of potassium channels, which appear to be necessary for specific contractile muscle 
behaviors (Kelley et al., 2018). Furthermore, other studies have recorded differences in calcium 
signaling across brain regions, with hippocampal astrocytes being more receptive to neuronal 
stimulation than striatal astrocytes (Chai et al., 2017), a property that may facilitate plasticity 
and synaptic potentiation (Adamsky et al., 2018). Recent development in multiomics 
technology, which surveys transcriptional and epigenetic profiles with unprecedented, 
genome-wide resolution and high-throughput, will further advance our understanding of 
functional diversity of astrocytes in health and disease (Cahoy et al., 2008; Hasel et al., 2021; 
Zeisel et al., 2018) 
It is still unclear where the astrocyte’s diversity is originating from. Interestingly, contrary to 
other glial cell types that are ontologically younger, it is possible to identify astrocyte-like cells 
in any organism with a central nervous system. Astroglia in the C.Elegans and the Drosophila 
express glutamate and gamma aminobutyric acid (GABA) receptors, and have been implicated 
in axon guidance, suggesting that they may play roles that are analogous to their mammalian 
counterpart (Rival et al., 2004; Soustelle et al., 2002). In simpler organisms, however, the 
astroglial population appears to be rather homogeneous. Throughout evolution, astrocyte 
subtypes have, instead, emerged in concomitance with the expanding neuronal subtype 
collection that characterizes the brain of higher organisms (Freeman and Rowitch, 2013). In 
fact, the growing number, complexity and diversity of astroglia that have paralleled the 
increasing breadth of nerve cell diversification, may have directly contributed to the enhanced 
cognitive capabilities characterizing the mammalian, and particularly, the human brain 
(Freeman and Rowitch, 2013). During development, astrocytes are mostly generated from 
ventricular zone radial glia, although contribution of marginal zone progenitors and neural/glial 
antigen 2 (NG2) glia has also been recorded (Ge et al., 2012; Huang et al., 2014), and they are 
first seen in the mouse brain after the neurogenic phase (i.e., around embryonic day 16)(Miller 
and Gauthier, 2007). The majority of cells populating the adult brain are, however, generated 
postnatally, from astrocyte precursors that proliferate extensively to give rise to glia that remain 
in close proximity (Rowitch and Kriegstein, 2010). The astroglial diversity may be encoded by 
cell autonomous factors, so that different astrocyte subpopulations are, for instance, generated 
from a diverse population of precursors. In the brain, this could be the case, for instance, for 
juxtavascular and pial astrocytes, which originate from distinct progenitors (Bribian et al., 
2016; Figueres-Onate et al., 2016). In addition, thalamic astrocytes and neurons from distinct 
sensory nuclei are clonally related and share region-specific signatures, which have been shown 
to be retained even when astrocytes are reprogrammed into region-appropriate thalamic 
neurons using the same transcription factor overexpression protocol (Herrero-Navarro et al., 
2021). Conversely, their differences may be dictated by surrounding environmental factors 
(Ben Haim and Rowitch, 2017) and neighboring cells, such as the neuronal subtypes they come 
in contact with (Kelley et al., 2018; Lanjakornsiripan et al., 2018). Interestingly, spinal cord 
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astrocyte progenitors are subjected to dorsoventral gradients of secreted factors, which 
determine their radial patterning and the establishment of subpopulation of white matter 
astrocytes in the mature spinal cord (Hochstim et al., 2008). Comprehensive fate-mapping 
studies combined with transcriptional analysis, which are currently being established (Ratz et 
al., 2021; Weinreb et al., 2020), will let us examine to what extent functional heterogeneity is 
developmentally determined. 
Within the scope of this thesis, the question of astrocyte heterogeneity is relevant for better 
understanding the extent to which parenchymal astrocytes can be recruited to generate new 
neurons that contribute to regenerative repair after injury. As briefly introduced earlier and 
further discussed below, there exist specialized astrocyte populations that act as neural stem 
cells and produce new neurons throughout life. These cells are, however, rare and only 
restricted to two small regions of the brain, namely the subventricular zone and the dentate 
gyrus of the hippocampus (Gage, 2019; Gould, 2007). They can mount reactive responses after 
injury and increase proliferation (Faiz et al., 2015), but the extent to which they are able to 
contribute to regenerating neurons lost to injury is limited by their small population size 
(Arvidsson et al., 2002). By contrast, parenchymal astrocytes are numerous, making up 50% 
of all neural cells in the brain, and work contained in this thesis, as well as published by other 
laboratories (Nato et al., 2015), shows that they can be recruited into the neurogenic program 
(Magnusson et al., 2014; Magnusson et al., 2020; Zamboni et al., 2020). From our work is, 
however, evident that astrocytes display some differences to the extent to which they can reveal 
their neurogenic potential. Striatal astrocytes, indeed, readily generate neural progenitors after 
either exposure to an ischemic stroke or depletion of Notch signaling (Magnusson et al., 2014; 
Magnusson et al., 2020). By contrast, Notch signaling inhibition in the cortex is not sufficient 
to drive their cell fate conversion, which is only evident when animals are also subjected to an 
injury (Zamboni et al., 2020). On the other hand, our work in the cortex suggests that the same 
stimuli are able to recruit astrocytes beyond a specific cortical region, and that this potential 
can be displayed by glia across cortical layers (Zamboni et al., 2020). It remains to be 
established, however, whether the differences we have recorded are based upon cell-intrinsic 
factors or whether they are determined by the surrounding microenvironment. Seminal 
transplantation studies (Gage et al., 1995; Herrera et al., 1999) have suggested that the cortex 
may be a particularly hostile environment for survival of neural progenitors. This may hinder 
cell fate conversion of Notch-depleted astrocytes, which need instead additional stimulations 
in order to unlock their neurogenic program. Similarly, increased exposure to trophic blood- 
and cerebrospinal fluid-borne factors may give striatal astrocytes an advantage in their 
commitment to the neuronal lineage fate transition (Ihrie and Alvarez-Buylla, 2011; Sirko et 
al., 2013; Tavazoie et al., 2008). 
 
2.2 REACTIVE GLIOSIS 
Astrocytes have been known to respond to injury for over a hundred years, but their 
contributions have largely been neglected until recently. In their review from 2010, Sofroniew 
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and Vinters were among the firsts that attempted to offer a broad and comprehensive definition 
of astrocyte reactivity (Sofroniew and Vinters, 2010). Since then, a vast number of findings 
have brought considerable progress to the study of reactive astrocyte diversity (Hasel et al., 
2021; Moulson et al., 2021; Sofroniew, 2020; Zamanian et al., 2012), the molecular regulators 
of reactivity (Escartin et al., 2021; Liddelow and Barres, 2017; Liddelow et al., 2017), as well 
as the functional contribution to the injury microenvironment and surrounding cellular 
communities (Guttenplan et al., 2021; Han et al., 2021; Sofroniew, 2020). Astrocyte reactivity 
is, now, considered to be a spectrum of molecular, functional, and structural changes that 
sometimes lead to cell proliferation (Sofroniew, 2020; Wilhelmsson et al., 2006; Zamanian et 
al., 2012). Their response to injury is heterogeneous and context-dependent, varying based on 
type and severity of the insult (Zamanian et al., 2012), as well as along spatiotemporal axes 
(Hasel et al., 2021; Li et al., 2014; Rakers et al., 2019). Molecular and cellular changes that are 
common across diseases are the upregulation of intermediate filament proteins, such as glial 
fibrillary acidic protein (Gfap), Vimentin, and Nestin, the astroglial action on the extracellular 
milieu, and the interaction with immune cells (Zamanian et al., 2012). 
According to Sofroniew (2020), reactive astrocyte responses can be divided into two broad 
categories based on whether glia are recruited into cell division. Non-proliferative reactive 
astrocytes are seen in systemic inflammatory diseases and neurodegenerative conditions. They 
tend to maintain their territorial domain and engagement with the surrounding neuronal and 
glial cells. Proliferative astrocytes, on the other hand, are seen in traumatic injury and tend to 
be recruited to form borders against areas of fibrosis and tissue inflammation. The diverse 
reactive response may in part be attributed to intrinsic determinants, with proliferating 
astrocytes largely originating from juxtavascular astrocytes (Bardehle et al., 2013; Frik et al., 
2018; Lange Canhos et al., 2021) or ependymal cells (Carlen et al., 2009; Sabelstrom et al., 
2013). Notably, the lesion bordering response of the proliferative reactive glia has classically 
been understood as a scarring process with detrimental and anti-reparative characteristics. 
However, conditionally ablating genes implicated in structural changes of glial morphology, 
such as Gfap and Vimentin (Li et al., 2008b; Liu et al., 2014) or that regulate proliferation and 
migration of reactive cells, such as Stat3 (Signal Transducer And Activator Of Transcription 
3) and Notch1, show that impaired border formation is linked to increased spread of 
inflammation and secondary damage, as well as greater neuronal death and functional 
impairment (Shimada et al., 2011; Wanner et al., 2013; Xie et al., 2020). Furthermore, unlike 
attenuation of the fibrotic scar, which facilitates regeneration of neuronal processes after spinal 
cord injury (Dias et al., 2018; Goritz et al., 2011), presence of astrocytes along the borders of 
the scar tissue does not seem to impede axonogenesis (Anderson et al., 2016; Anderson et al., 
2018). In fact, recent studies by Chen and colleagues (2018) and Xie and colleagues (2020) 
show that increasing proliferation and border formation may actually contribute to enhanced 
repair after spinal cord injury. Notably, however, another study has shown that neuroblast 
migration towards the ischemic lesion is impeded by reactive astrocytes in the striatum 




Another prominent classification of reactive astrocytes is based on their pro- or anti-
inflammatory action. Once again, different phenotypes arise in a context-dependent manner. 
Pro-inflammatory, neurotoxic astrocytes (“A1”) have, for instance, been recorded in bacterial 
infection, which is experimentally modelled with systemic administration of 
lipopolysaccharide (Liddelow et al., 2017), as well as neurodegenerative diseases (Liddelow et 
al., 2017; Rodriguez-Arellano et al., 2016), and are progressively more prominent in the aging 
brain, where they may contribute to cognitive decline due to their role in inflammation and 
synapse disruption (Clarke et al., 2018; Orre et al., 2014; Rodriguez-Arellano et al., 2016). This 
cell state is characterized by activation of the classical complement cascade (i.e., C1s, C3, and 
C4) (Zamanian et al., 2012), a process induced by neighboring neuroinflammatory microglia 
(Liddelow et al., 2017), that may represent a priming factor for neurodegeneration (Clarke et 
al., 2018; Liddelow et al., 2017). Neuroprotective reactive glia (“A2”) are instead a hallmark 
of traumatic and ischemic lesions and have been shown to secrete cytokines and neurotrophic 
factors, such as interleukin 6 (Il6) and thrombospondins, that help resolving inflammation and 
rebuilding synapses (Christopherson et al., 2005; Zamanian et al., 2012). Zamanian and 
colleagues (2012) have compared the transcriptional profile of these two subsets of astrocytes 
and found prominent differences in gene expression, reflecting the highly diverse set of 
functions each group undertakes. The authors, however, warn that the binary classification may 
actually represent an oversimplification and that reactive gliosis may instead be more diverse 
than observed in their study (Liddelow and Barres, 2017). Recent developments in single-cell 
omics and improvements in astrocyte isolation techniques, have allowed researchers to 
substantially increase the throughput of transcriptional experiments and revealed greater 
diversity in the reactive gliosis response (Hasel et al., 2021). Accordingly, a recent consensus 
statement published by major exponents in the field, recommends avoiding binary 
classifications and focusing, instead, on the diverse molecular and functional responses of 
reactive astrocytes (Escartin et al., 2021). 
Interestingly, reprogramming studies that aim at using parenchymal astrocytes to induce new 
neurons have shown that efficiency of the astrocyte-to-neuron conversion is enhanced after 
injury (Robel et al., 2011; Sirko et al., 2013), and have, thus, proposed that reactive gliosis may 
be necessary in order to unveil the neurogenic potential of astrocytes. In support of this notion 
is the fact that reactive astrocytes and neurogenic astrocytes from the subventricular zone share 
several molecular and morphological characteristics (Magnusson and Frisen, 2016). Our 
analysis of astrocyte-mediated neurogenesis in the injured cortex, however, suggest that 
initiation of the neurogenic program can occur independent of reactive gliosis and shows, in 
fact, that reactive astrocytes rarely express the pro-neuronal transcription factor achaete-scute 




3 ADULT NEUROGENESIS 
 
“It is this potential for plasticity of the relatively stereotyped units of the 
nervous system that endows each of us with our individuality.”  
¾ Eric R. Kandel, 2000 
 
Neurogenesis is the process through which neural stem cells, which are located in specialized 
niches across the brain, give rise to new neurons. It was traditionally believed that the brain, 
once development had ended, would be immutable and that no new neurons could be created 
and added to the established neural circuits. The seminal work of Altman and Das in the 1960s, 
shows incorporation of radioactive thymidine in the rat dentate gyrus, suggesting for the first 
time that new cells are added to the adult brain (Altman and Das, 1965). A decade later, Kaplan 
and Hinds replicated these results and used electron microscopy to demonstrate that the adult-
born cells in the dentate gyrus were in fact neurons (Kaplan and Hinds, 1977). Nottebohm, 
subsequently, studied the songbird brain and demonstrated the seasonal occurrence of bursts 
of neurogenesis (Nottebohm, 1989). These initial experiments were followed by other studies 
confirming that adult-born neurons are present across mammalian species, including humans 
(Eriksson et al., 1998). For decades, the notion of adult neurogenesis was met with skepticism 
and intense criticism. Conceptually, the scientific community was concerned that if indeed new 
neurons were generated and added to the established neural circuit of the mature brain, 
memories and even the concept of self-identity could not be stable. Since the early 1990s, 
however, experiments validating adult neurogenesis with independent measures, along with 
physiological and functional analyses, have accumulated exponentially, and eventually laid the 
disbelief to rest. Surprisingly though, the recent publication of two papers with contradicting 
results has reignited the debate. Sorrells and colleagues (2018) suggested that human 
hippocampal neurogenesis would sharply decrease to undetectable levels shortly after 
childhood. By contrast, Boldrini and colleagues (2018) support previous evidence and show 
high numbers of neural progenitor cells throughout the lifespan. Arguably, their findings likely 
reflect the challenges encountered when working with human postmortem tissue and the need 
for reliable detection methods to unambiguously identify neural stem cells and young neurons. 
Indeed, there are several sources of variation that could influence immunostaining experiments 
and lead to drawing contradictory conclusions, namely the post-mortem delay, tissue 
preservation and fixation, but also physical and psychological state of the subjects, which is 
particularly important in the context of hippocampal neurogenesis (van Praag et al., 2000). 
Rigorous tissue collection and documentation of the subjects’ medical history, along with the 
use of systematic protocols and quantification methods, have led to more convincing results on 
the persistence of hippocampal neurogenesis throughout life (Moreno-Jimenez et al., 2019) and 
how this changes in the presence of neurodegenerative diseases (Terreros-Roncal et al., 2021). 
Moving forward, the use of more sophisticated approaches, such as fate-mapping studies and 
transcriptional analysis, will lead to a greater understanding of the cellular and molecular 
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components of adult neurogenesis in the human brain. A few attempts have already been made 
to identify and characterize neurogenic cells with single-cell transcriptomics in the human 
(Ayhan et al., 2021; Habib et al., 2017), however studies may have been underpowered or have 
misclassified other cell types as neural progenitors (Franjic et al., 2021; Sorrells et al., 2021). 
A recent publication leveraged snRNA-seq across species to show that human dentate gyrus 
cells rarely co-cluster with neural progenitors from mouse, pig, or monkey (Franjic et al., 2021). 
In our study (Dumitru, manuscript), we identified neural stem and progenitor cells from young 
human brains (aged 0 to 5 years old), learned their transcriptional profile, and used machine 
learning algorithms to determine the minimum marker combination to define each state along 
the neurogenic program. These molecular signatures were, subsequently, used to reveal cells 
of adult dentate gyrus datasets, with transcriptional profiles indicative of a neurogenic cell state. 
 
3.1 CANONICAL NEUROGENESIS 
New neurons are added throughout life, but their generation is restricted to two small regions 
of the mammalian brain, namely the subventricular zone, where neural stem cells are found 
lining the walls of the lateral ventricles, and the dentate gyrus of the hippocampus (Gage, 2019; 
Gould, 2007). Neurogenesis occurs through activation of neural stem cells, which proliferate 
and give rise to neural progenitors. These then migrate toward their target neural circuit, where 
they differentiate into mature neurons. The process of activation of neural stem cells within the 
two neurogenic niches is similar (Llorens-Bobadilla et al., 2015; Shin et al., 2015), although 
their post-mitotic fates diverge as the neurogenic progeny activates transcription factors 
implicated in the specification of the region-appropriate neural subtypes. Adult neural stem 
cells originate from a subset of developmental radial glia that ceases to proliferate mid-
gestation, only to exit quiescence in adulthood to initiate gliogenic or neurogenic programs 
throughout life (Fuentealba et al., 2015; Furutachi et al., 2015). Albeit seemingly 
homogeneous, the adult neural stem cell population encompasses a collection of cells primed 
for distinct lineage fates, which are instructed based on embryonically-determined cell-
autonomous cues (Fuentealba et al., 2015), as well as environmental exposure to morphogen 
gradients, such as Wnt, which primes dorsal subventricular zone neural stem cells towards the 
oligodendrocyte lineage (Azim et al., 2014; Ortega et al., 2013), or sonic hedgehog (Shh), 
which instructs specification of deep olfactory bulb granule cell in ventral neural stem cells 
(Ihrie et al., 2011). Cell states along the entire neurogenic lineage can be found at any time in 
the germinal niche, which has enabled computational reconstruction of the complex cascade of 
molecular events leading to the generation of new neurons (Hochgerner et al., 2018; Llorens-
Bobadilla et al., 2015; Shin et al., 2015; Zywitza et al., 2018). The quiescent neural stem cell 
state is characterized by expression of prominin-1 (CD133) and of astroglial markers, such as 
Gfap and aquaporin 4 (Aqp4) (Llorens-Bobadilla et al., 2015), and presents high glycolytic 
metabolism and low translational activity (Llorens-Bobadilla et al., 2015; Shin et al., 2015). 
Quiescent neural stem cells also express higher levels of membrane receptors, reflecting their 
reliance on environmental cues to maintain their dormant state (Shin et al., 2015). By contrast, 
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activated neural stem cells, which downregulate expression of these receptors, become 
progressively less responsive to the influence of the niche, so that they can even complete 
differentiation ex vivo (Costa et al., 2011). Activated neural stem cells induce expression of 
epidermal growth factor (Egf) receptor (Codega et al., 2014; Marques-Torrejon et al., 2021), 
along with genes implicated in ribosomal biogenesis (Baser et al., 2019), while gene sets related 
to glial functions (i.e., ion transport and glycolytic metabolism) are progressively silenced 
(Dulken et al., 2017; Llorens-Bobadilla et al., 2015). Actively dividing cells, expressing 
classical cell cycle genes, such as proliferating cell nuclear antigen (Pcna) and marker of 
proliferation Ki-67 (Mki67), are characterized by high levels of genes involved in the protein 
synthesis machinery (Baser et al., 2019), and concomitant upregulation of neuronal lineage-
specific transcription factors (Llorens-Bobadilla et al., 2015). Interestingly, clonal analyses 
have suggested that activated neural stem cells are rapidly depleted after generating their 
progeny, while only a subset of cells contribute to the long-term self-renewal capacity of the 
population (Calzolari et al., 2015; Obernier et al., 2018). Furthermore, there is an increased 
tendency to quiescence in the aging subventricular zone to avoid depletion of the neural stem 
cell pool (Kalamakis et al., 2019). However, once activated older neural stem cells proliferate 
and differentiate at similar rates compared to the younger counterparts and display minimal 
transcriptional differences (Kalamakis et al., 2019). Similarly, Harris and colleagues (2021) 
have shown that albeit neurogenesis rapidly decreases in the dentate gyrus with age, the neural 
stem cell pool is maintained throughout life through an increased propensity to returning to 
quiescence, a process regulated by degradation of the pro-neuronal transcription factor Ascl1 
(Urban et al., 2016).   
The germinal niche is characterized by a privileged microenvironment, directly contacting 
cerebrospinal fluid and vasculature, and interacting with several types of neuronal and glial 
cells that participate in the neurogenic process (Ihrie and Alvarez-Buylla, 2011). Contrary to 
other parenchymal areas of the brain, characterized by a tightly regulated blood-brain barrier, 
the subventricular zone gains direct access to secreted molecules through an increased leakage 
of blood serum into the area (Tavazoie et al., 2008). Additionally, the vascular niche influences 
quiescence via direct contact of endothelial cells and quiescent neural stem cells, expressing 
Jagged-1 ligand and Notch receptor, respectively (Ottone et al., 2014). Similarly, contact with 
the cerebrospinal fluid regulates neural stem cells activity (Silva-Vargas et al., 2016) and the 
flow of the fluid through the ventricular system directs migration of neuroblasts along the 
rostral migratory stream and into the olfactory bulbs (Sawamoto et al., 2006). Active 
proliferation of neural stem cells progressively decreases as a function of age, likely due to 
lower availability of growth and neurotrophic factors, including bone morphogenic protein 5 
(BMP5) and insulin-like growth factor 1 (IGF1) (Silva-Vargas et al., 2016). Interestingly, 
heterochronic infusion of cerebrospinal fluid from juvenile mice is sufficient to restore youthful 
rates of neural stem cell expansion in aged brains (Silva-Vargas et al., 2016). The niche 
encompasses also a collection of glia cells and neural innervations that regulate stem cell 
behavior. Importantly, neural stem cells themselves have an active feedback system through 
which activated cells promote quiescence of the neighboring cells through Notch and Nogo 
 
 13 
signaling, to avoid depletion of the neural stem cell pool (Kawaguchi et al., 2013; Rolando et 
al., 2012). Ependymal cells modulate BMP signaling, known for its role in promoting 
astrogliogenesis at the expense of neuronal lineage commitment (Lim et al., 2000). 
Interestingly, ependymal cells are another example of latent neural stem cells, which exit 
quiescence and acquire neurogenic properties after stroke, through a process that requires 
canonical Notch signaling inhibition (Carlen et al., 2009). Non-neurogenic niche astrocytes 
play roles in maintaining neural stem cell quiescence through secretion of Notch ligands 
Jagged-1 and Delta like non-Canonical notch ligand 1 (Dlk-1) (Ferron et al., 2011), while they 
also regulate proliferation and differentiation through production of Wnt ligands (Adachi et al., 
2007). Similarly, microglia regulate neurogenesis in both the developmental (Zhu et al., 2008) 
and the adult brain via secretion of factors, such as Transforming growth factor beta (TGFb) 
and IGF1 (Battista et al., 2006; Ueno et al., 2013). Finally, several neuronal populations 
innervate the niche and promote neural stem cell activity via neurotransmitter release (Tong et 
al., 2014). 
 
3.2 FUNCTIONAL IMPACT OF ADULT-BORN NEURONS 
In hippocampal neurogenesis, radial glial cells are found in the subgranular zone of the dentate 
gyrus (Seri et al., 2001) where they give rise to highly proliferative intermediate progenitors 
and subsequently neural lineage-committed progenitors (Bonaguidi et al., 2011). The 
neurogenic progeny, the neuroblasts, then migrates short distances and populate the granule 
cell layer, where they complete maturation (Goncalves et al., 2016b) extending their dendrites 
towards the molecular layer and their axon through the hilus and cornu ammonis (CA)3 and 
CA2 subregions, where they make synaptic contact with pyramidal neurons and mossy cells 
by 2-3 weeks post-mitosis (Llorens-Martin et al., 2015; Toni et al., 2008; Zhao et al., 2006). It 
has been estimated that as many as 9000 new neurons are generated every day in the rodent 
hippocampus (Cameron and McKay, 2001). Likewise, hippocampal neurogenesis remains a 
robust process also in the human brain (Boldrini et al., 2018; Knoth et al., 2010; Moreno-
Jimenez et al., 2019; Spalding et al., 2013). Immature neurons are electrophysiologically active 
already one week after mitosis, but unlike mature granule cells, they respond with excitation to 
GABAergic inputs (Chancey et al., 2013). Furthermore, they present highly plastic synaptic 
activity and have a lower threshold for long-term potentiation (Ge et al., 2007), making them 
hyper-responsive to incoming signals. Although hippocampal radial glia only generate one type 
of neuron, namely granule cells, different regions of the hippocampus are implicated in distinct 
cognitive and affective behaviors, suggesting that new neurons originated across the 
dorsoventral axis of the hippocampus may be implicated in different functions (Ayhan et al., 
2021; Cope and Gould, 2019). 
The hippocampal formation is known as a gateway to memory, which guides formation of new 
memories through the establishment of connections between pre-existing neurons. In this 
context, synaptic plasticity is crucial to sustain life-long learning abilities and hippocampal 
neurogenesis also aids this process of memory formation. Furthermore, neurogenesis has been 
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linked to learning of pattern separation (Clelland et al., 2009), as well as forgetting of old 
memories (Akers et al., 2014). The unique electrophysiological properties of young neurons 
allow them to be highly receptive to new information that may be carried with weaker signal 
due to their connections not yet being fully established. Interestingly, the rate at which new 
neurons are added to the dentate gyrus is influenced by genetic and environmental factors. 
Major depressive disorder is associated with lower levels of neurogenesis and adult-born 
neurons are virtually depleted in the brains of individuals suffering from Alzheimer’s disease 
(Berger et al., 2020; Moreno-Jimenez et al., 2019). The impaired neurogenic program may be 
at the basis of the memory problems encountered in the neurodegenerative condition, but it 
may also be associated with affective dysregulation since the hippocampus is part of the limbic 
system, a collection of brain structures that participate in emotional regulation (Anacker and 
Hen, 2017; Anacker et al., 2018). Conversely, hippocampal neurogenesis has been shown to 
benefit from environmental experiences, such as learning, physical exercise and exposure to an 
enriched environment (van Praag et al., 2000), all of which increases proliferation and survival 
of the progenitors, as well as enhances complexity and maturation of afferent and efferent 
connections, and in turn, benefits cognitive performance (Llorens-Martin et al., 2015).  
The functional role of adult-born neurons from the subventricular zone is less well understood. 
In the subventricular zone, neural stem cells are found at the basal side of the ependymal cell 
layer lining the lateral ventricles (Kriegstein and Alvarez-Buylla, 2009). They extend an apical 
process passed the ependymal cell layer to reach the cerebrospinal fluid and another that makes 
contact with the vasculature (Doetsch et al., 1999), emphasizing the importance of these two 
compartments in regulating neurogenesis. Activated neural stem cells give rise to transit 
amplifying cells, which expand rapidly before generating neuroblasts that migrate toward their 
target neural circuit. In rodents, neuroblasts move along the rostral migratory stream to reach 
and innervate the olfactory bulb (Belluzzi et al., 2003; Doetsch et al., 1999). Once there, they 
mature into interneurons that may participate in olfactory discrimination tasks (Bragado Alonso 
et al., 2019). It has been shown that neural stem cells along the walls of the subventricular zone 
are regionally specialized since embryogenesis (Fuentealba et al., 2015) and generate 
neuroblasts that mature into distinct neuronal subtypes in the olfactory bulb (Delgado and Lim, 
2015; Mizrak et al., 2019). The dorsal domain of the subventricular zone gives rise to 
superficial olfactory bulb granule cells and dopaminergic periglomerular cells, whereas the 
ventral domain specifies maturation of deep olfactory bulb granule neurons and calbindin-
expressing periglomerular cells (Merkle et al., 2007). Interestingly, no neurogenesis occurs in 
the human olfactory bulb (Bergmann et al., 2012), which may reflect the decreased reliance of 
our species on the sense of smell, compared to mice. Instead, neuroblasts in humans seem to 
migrate to the striatum, where they mature into calretinin-expressing interneurons, which are a 
rare population in rodents but make up about 10% of interneurons in the human striatum (Ernst 
et al., 2014).  The functional relevance of striatal neurogenesis is still enigmatic, although it is 
striking that new neurons are predominantly added to the medial striatum, which is part of the 
limbic system, receiving afferents from medial prefrontal and anterior cingulate cortex. The 
human brain is not unique in displaying striatal neurogenesis in homeostatic conditions, which 
 
 15 
has also been recorded in rats (Dayer et al., 2005) and rabbits (Luzzati et al., 2006). These 
model organisms could, thus, be exploited in the future to investigate physiological properties 
and roles of the adult-born neurons and help us clarify their functional relevance in humans. 
 
3.3 REACTIVE NEUROGENESIS 
While at the population level, neural stem cells have multilineage and self-renewal potential, 
the individual cell appears to be fate-biased since embryonic development (Fuentealba et al., 
2015; Merkle et al., 2007) and can quickly be depleted after one or two rounds of expansion 
(Obernier et al., 2018), which could hinder efficient brain repair after injury. However, several 
studies have demonstrated that injury elicits a process of reactive neurogenesis that promotes 
recruitment of quiescent stem cells (Llorens-Bobadilla et al., 2015), increases their lineage 
plasticity (Faiz et al., 2015), and reroutes their differentiated progeny towards sites of damage 
(Arvidsson et al., 2002; Faiz et al., 2015). After an ischemic event, quiescent neural stem cells 
have shown to selectively respond to injury-induced interferon gamma activity, which primes 
them for activation (Llorens-Bobadilla et al., 2015). Furthermore, in response to stroke, neural 
stem cells of the subventricular zone display trilineage potential and generate neurons, 
oligodendrocytes, as well as astrocytes to attempt to repopulate the damaged area (Li et al., 
2010). Some reports have suggested that neurogenic subventricular zone cells are also able to 
generate region-appropriate neurons in the target area, such as medium spiny neurons that have 
been recorded in the striatum after stroke (Arvidsson et al., 2002), albeit these findings remain 
controversial (Liu et al., 2009). Astrocytes generated by subventricular zone cells in response 
to injury may participate with resident reactive glia in restricting tissue damage. They also 
display distinctive features and may exhibit increased capacity for repair (Faiz et al., 2015). 
Demyelinating lesions elicit lineage-fate switch of neuron-committed progenitors to favor 
oligodendrogenesis (Jablonska et al., 2010). After stroke, subventricular zone neuroblast 
migrate towards striatal sites of damage. The partial rerouting of the progenitors occurs along 
newly generated blood vessels (Thored et al., 2007) and is sustained for several months after 
the ischemic event has occurred (Thored et al., 2006). Nevertheless, a minority of injury-
induced neurogenic cells survive long-term in the striatum and only a small percentage (about 
0.2%) of the neurons lost to injury is eventually replaced (Arvidsson et al., 2002).  
Interestingly, the brain encompasses cells that can be viewed as latent neural stem cells, whose 
regenerative potential is revealed in response to injury. Injury prompts a bidirectional fate 
switch between the two main cellular components of the subventricular zone, namely neural 
stem cells and ependymal cells, a process regulated by Ephrin B2, downstream of Notch 
signaling (Nomura et al., 2010). In fact, ependymal cells, which are generally quiescent in 
homeostatic conditions, have shown trilineage potential when cultured in vitro (Meletis et al., 
2008), and have demonstrated the ability to proliferate robustly after brain and spinal cord 
injury, and to generate neuroblasts, astrocytes and oligodendrocytes (Barnabe-Heider et al., 
2010; Carlen et al., 2009; Llorens-Bobadilla et al., 2020; Sabelstrom et al., 2013). Interestingly, 
the latter lineage is not favored after spinal cord injury, although multiomic analysis has 
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demonstrated a permissive chromatin state for oligodendrogenic gene expression programs 
(Llorens-Bobadilla et al., 2020). After injury, ectopic expression of the transcription factor 
Olig2 instructs ependymal cells towards generation of oligodendrocytes that myelinate and 
appear transcriptionally and functionally comparable to local glia (Llorens-Bobadilla et al., 
2020). This suggests that learning the transcriptional and epigenetic landscape of canonical and 
latent neural stem cells may guide design of regenerative therapies to replace specific cell types 
lost to injury. 
Reactive neurogenesis can also occur ectopically, at the lesion site, from resident cells that can 
reveal a latent neurogenic program. This has been demonstrated for parenchymal astrocytes, 
which generate new neurons in the striatum following ischemic damage (Magnusson et al., 
2014), as well as an experimental model of Huntington’s disease (Nato et al., 2015). The 
recruitment of astrocytes into neurogenesis is controlled by Notch signaling inhibition, which 
is by itself sufficient to trigger a similar response in the striatum in the absence of injury 
(Magnusson et al., 2014). Once engaged, resident glia enter a neurogenic program that is 
comparable to canonical neural stem cell behavior (Magnusson et al., 2020), generating transit 
amplifying progenitors and neuroblasts, before maturing into striatal interneurons (Magnusson 
et al., 2014). Interestingly, silencing of Notch signaling in the context of a cortical injury 
enables astrocytes from the somatosensory and the occipital cortices to mount a similar 
neurogenic response, a process that unfolds independent of reactive gliosis (Zamboni et al., 
2020). Several laboratories have also proposed NG2 cells as a possible source of new neurons 
based on observations that suggest trilineage potential of these cells when cultured in vitro 
(Kondo and Raff, 2000). The evidence for NG2 cell-mediated neurogenesis is, however, scarce 
and controversial both in physiological conditions, as well as in the context of injury (Kirdajova 
and Anderova, 2020). NG2 cells, however, have been shown to be a valuable target for in vivo 
reprogramming strategies, where they can generate multiple subtypes of neurons using ectopic 
expression of lineage-specific transcription factors (Heinrich et al., 2014; Pereira et al., 2017; 
Torper et al., 2015).  
The role of immune signals in neurogenesis is relevant but complex. Interferon gamma activity 
has been shown to prime quiescent stem cells for activation shortly after stroke (Llorens-
Bobadilla et al., 2015). Furthermore, injury-induced changes in the immune signals are 
sufficient to trigger regenerative responses in the zebrafish brain (Kyritsis et al., 2012), through 
gene regulatory mechanisms that are not active in canonical neurogenesis, but unique to the 
regenerating tissue (Kang et al., 2016). In mammals, studies have also suggested that 
inflammation is sufficient to trigger neurogenesis (Chapman et al., 2015). Microglia have been 
shown to regulate neurogenesis and plasticity in homeostatic conditions, both in the developing 
brain, as well as in the adult germinal niche. However, several investigations have shown that 
activation of the immune cells may also hinder neurogenesis. For instance, Liu and colleagues 
(2007) have shown that depletion of activated microglia in the chronic phase of stroke 
supported survival and maturation of new neurons after stroke. Similarly, Ekdahl and 
colleagues (2003) suggest that survival of newly generated hippocampal neurons is negatively 
impacted by the extent of microglia activation. Furthermore, mimicking bacterial infections 
 
 17 
with lipopolysaccharide administration is associated with a shift to a pro-inflammatory 
phenotype of microglia, which is linked to impaired neurogenesis (Ekdahl et al., 2003). Finally, 
in aging and neurodegeneration, microglia adopt a pro-inflammatory phenotype that may 
impair neurogenesis (Biscaro et al., 2012; Sierra et al., 2007). Altogether, reports studying the 
involvement of immune cells in the regulation of reactive neurogenic responses suggest that 
their implication can be either favorable or detrimental at different stages of disease 
progression, as well as depending on disease severity. 
The functional relevance of the injury-induced neurons is unclear, but it may differ based on 
the type of injury and the site at which neurogenesis is occurring. Interestingly, epilepsy is 
associated with increased proliferation of dentate gyrus radial glia and faster maturation of 
granule cells. Yet, long-lasting epilepsy is linked to cognitive decline and inhibiting seizure-
induced neurogenesis has been shown to directly prevent impairment, as well as lower the risk 
for chronic seizures (Cho et al., 2015). Similarly, a recent study has shown that aberrant 
hippocampal neurogenesis recorded after stroke exacerbates injury-related symptoms of 
cognitive impairment (Cuartero et al., 2019). It is possible that abnormal rates of generation 
and maturation of neurons lead to the establishment of aberrant connections in the neural 
circuit, which in turn can alter excitability of the dentate gyrus (Overstreet-Wadiche et al., 
2006). Arguably, even the process of reactive neurogenesis recorded at the injury sites, which 
leads to the replacement of just a small proportion of lost neurons, is unlikely to contribute to 
efficient repair, as highlighted by the fact that patients who suffer a stroke may never regain 
full functionality. However, reports have shown that specifically ablating neural progenitor 
populations shortly after ischemic injury, leads to worsened outcomes in terms of lesion 
volumes and mortality (Butti et al., 2012). The reactive response of subventricular zone cells 
appears to be beneficial, in that it provides protection against excitotoxic damage induced by 
glutamatergic neurons after stroke (Butti et al., 2012) Furthermore, injury-induced neuronal 
cells that survive long-term, successfully integrate in the local circuit (Hou et al., 2008), 
suggesting that their existence may have some beneficial contribution, and that further 
promoting their survival may prove valuable to enhance their positive influence on recovery 
(Wang et al., 2012). 
Even with injury-mediated changes in the rate of neurogenesis and lineage plasticity of neural 
stem cells, the brain remains inefficient at repairing itself. The restricted number of neural stem 
cells found in the adult brain is unlikely to be sufficient to repopulate brain regions afflicted by 
widespread neuronal death. Furthermore, most neural progenitors and neurons induced after 
injury die shortly after they are generated. Thus, novel strategies for regenerative repair could 
be designed in order to promote survival of the neural stem cell progeny, as well as to stimulate 
differentiation into region-appropriate neurons that are functionally comparable to the original 
cells. Furthermore, the discovery that resident parenchymal cells may activate a neurogenic 
program in response to injury opens the doors to regenerative therapies that target these 
abundant cell types to achieve more widespread neuronal replacement. These topics are 
discussed further in the next chapter of this thesis. 
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4 CELL REPLACEMENT AND REGENERATION 
 
“Awakening, basically, is a reversal of this: the patient ceases to feel the 
presence of illness and the absence of the world, and comes to feel the absence 
of his illness and the full presence of the world.”  
¾ Oliver Sacks, 1973 
 
Despite lifelong generation of new neurons in the specialized niches of the brain, the central 
nervous system of mammals is largely inefficient at repairing itself after widespread damage 
and neuronal death. Ultimately, cell replacement therapies for neurologic conditions aim at 
repopulating the injured brain with the appropriate cell types that were lost to injury, allowing 
them to integrate correctly into the neuronal network, thus, providing functional recovery. Two 
main categories of cell replacement therapies are currently being explored, namely cell 
transplantation and recruitment of endogenous cells. Aside from the specific strengths and 
limitations of the therapeutic approaches, each strategy will have to overcome significant 
hurdles imposed by the target tissue in order to become successful. Indeed, the adult brain 
offers an unsupportive environment for the young neurons to achieve maturation and functional 
integration, whatever source these cells are originating from. Much unlike in the embryonic 
brain, characterized by a supportive microenvironment where neurogenesis is prevalent at the 
expense of the gliogenic fate, starting at birth and throughout life, gliogenesis becomes the 
default fate (Gotz et al., 2016). Indeed, early transplantation studies have shown that neural 
progenitors, with recognized neurogenic potential in vitro, are unable to generate neurons when 
grafted to the adult brain, unless they are placed at the germinal niche (Herrera et al., 1999). 
The strong influence of a non-permissive environment is also evident in the context of 
reprogramming studies, where ectopic expression of neuronal fate determinants efficiently 
drives lineage conversion in vitro but proves considerably more challenging when attempted 
in vivo (Buffo et al., 2005; Grande et al., 2013). This may lead to the therapeutic cells 
differentiating into glial cells, or it may hinder their survival altogether. The developing brain 
is also characterized by the presence of a well-defined network of cells and chemoattractant 
signals that encourage progenitors’ migration and establishment of synaptic connections at 
their target sites (Gotz et al., 2016). In the adult brain, radial glia providing structural support 
to migrating cells are absent and sprouting axons are no longer guided by an abundance of 
signals that ensure path finding and connectivity with the appropriate cells. In fact, it was 
observed that, after transplantation of neural progenitors, the cells tended to form clusters 
around the injection site and did not display considerable migration (Ladewig et al., 2014). 
Interestingly, neural progenitors at different stages of maturation are differentially capable of 
migrating once transplanted, with cells at early or intermediate stages of differentiation 
covering the longest distances (Ganat et al., 2012). Similarly, in a mouse model of stroke, 
overexpression of Slit1, which is associated with neuronal migration, promoted movement of 
subventricular zone neuroblasts passed the reactive astrocyte layer limiting the injury site, and 
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led to greater repopulation of new neurons at the infarcted area (Kaneko et al., 2018). In another 
study, polysialic acid (PSA), a carbohydrate implicated in migration and synapse formation, 
was overexpressed in embryonic cells transplanted into a rodent model of Parkinson’s disease 
and shown to make cells more responsive to the scarce axon-guiding cue found in the adult 
brain and more efficient at establishing connections (Battista et al., 2014). Finally, the aging 
brain becomes progressively less plastic and is characterized by a generalized state of 
neuroinflammation (Biscaro et al., 2012; Sierra et al., 2007), which may be detrimental for 
survival, proliferation, and integration of newly generated cells. The situation becomes 
exacerbated after injury or in a brain afflicted by neurodegenerative diseases (Biscaro et al., 
2012), which are generally the targets of regenerative medicine efforts. Monje and colleagues 
(2003) have demonstrated that inflammation challenges the proliferative behavior of 
hippocampal neural stem cells, and that their activity can be restored through administration of 
non-steroidal anti-inflammatory drugs. Thus, combining replacement therapies with strategies 
that support survival and maturation of the newly generated cells, or that consider comorbidities 
of the disease, such as neuroinflammation, will likely prove greater potential in promoting 
regenerative repair. Additionally, considering that cell therapies are generally aimed at treating 
age-related neurological conditions, extensive investigation of their potential in aged animal 
models may support their translation into clinical application. 
 
4.1 REPLACEMENT THERAPY USING CELL TRANSPLANTATION 
The earliest attempts at promoting regeneration of injured brains date back to the 1970s when 
researchers succeeded in replacing degenerated dopaminergic neurons in a mouse model of 
Parkinson’s disease, effectively rescuing motor function (Perlow et al., 1979). Since then, 
replacement therapies utilizing exogenous sources of cells have been refined and, even, tested 
in clinical trials (Barker et al., 2015; Parmar et al., 2020). Multiple sources of cells for 
transplantation have been explored so far. Initial experiments utilized allografts of human fetal 
origin (Lindvall et al., 1990), which were shown to differentiate in situ, establish meaningful 
connections, and release neurotransmitters at desired sites. The outcomes for treating 
Parkinson’s disease with fetal ventro-mesencephalic tissue have been promising (Parmar et al., 
2020) and attempts have been made for restoring basal ganglia functionality in Huntington’s 
disease (Hauser et al., 2002), albeit with limited success owing to the poor survival rate of 
grafted cells (Cisbani and Cicchetti, 2014). Nevertheless, the use of human fetal tissue poses 
great limitations that hinders this strategy from becoming a therapy. Firstly, the scarce 
availability of the source and the large amounts required to repopulate an adult brain have led 
to a large number of surgeries being cancelled owing to the lack of tissue (Barker and 
consortium, 2019). Furthermore, there is poor control over the genetic background of the 
donors and the compositions of cells collected, because multiple fetal brains are used to treat 
each patients, and they may differ in age and the way they are being dissected, leading to high 
variability of the therapeutic material being delivered (Parmar et al., 2020). More recently, cell 
grafts from human embryos have also shown some therapeutic promise through successful 
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structural and functional integration in compromised neural networks (Barker, 2014; Falkner 
et al., 2016; Steinbeck et al., 2015). Interestingly, a study by Li and colleagues (Li et al., 2016) 
showed that a patient with Parkinson’s disease who received embryonic stem cell 
transplantation, retained some of the grafted cells for as long as 24 years, and these cells 
connected with the putamen through dopaminergic innervation. This suggests that the 
beneficial effect of cell transplantation derives from cell replacement, which is, in fact, the 
ultimate goal of the therapy. However, other studies have also observed bystander beneficial 
effects, such as increased survival of host neurons thanks to trophic support offered by the 
transplanted cells (Mendonca et al., 2015; Wang et al., 2013). Compared to fetal cells, 
pluripotent human embryonic stem cells (hESCs) are more easily accessible because cultures 
can be expanded virtually indefinitely. In addition, there is better control over the production 
and differentiation processes, which results in greater purity and decreased inter-batch 
variability (Parmar et al., 2020). However, embryonic stem cells still carry the risk of immune 
rejection and, therefore, need to be combined with immunosuppression. Furthermore, their 
pluripotent and self-renewal potential raises concerns regarding possible tumorigenicity. 
Notably, many studies in model organisms have been carried out and, so far, none has recorded 
problems of uncontrolled proliferation or tumor formation. However, the longer lifespan of the 
patients combined with the greater numbers of cells being injected may carry greater risks, 
which will be carefully evaluated in clinical trials (Parmar et al., 2020). These hurdles, as well 
as risks associated with immunosuppressive treatments, which still need to be imposed to avoid 
rejection of cell grafts, may be overcome with the use of induced pluripotent stem cells (iPSCs), 
which can be harvested in large numbers from the patient’s own organs (Takahashi and 
Yamanaka, 2006). Fibroblasts from the skin can be reprogrammed in vitro using refined 
differentiation protocols that allow correct patterning and maturation into midbrain 
dopaminergic neurons (Soldner et al., 2009). Specific neuronal and glial subtypes can now be 
reliably and efficiently generated from iPSCs through activation of key transcription factors 
(Canals et al., 2021). Nerve cells originated from iPSCs and transplanted into the brain have 
remarkable capacity for neurite outgrowth, and synthesis and release of neurotransmitters with 
potency and specificity that parallels that of endogenous cells (Kirkeby et al., 2012; Kriks et 
al., 2011). Stem cell transplants have demonstrated successful integration of grafted cells even 
in highly complex neocortical circuits in mouse models of Alzheimer’s disease, cortical injury, 
and stroke (Espuny-Camacho et al., 2017; Espuny-Camacho et al., 2013; Falkner et al., 2016). 
Importantly, as studies have shown that grafted cells may begin to bear pathological hallmarks 
of host neurons after transplantation (Li et al., 2008a), stem cell therapy has the potential 
advantage to be genetically engineered to withstand disease pathology, which is particularly 
relevant in case the cells to be injected directly derive from the patient (Kikuchi et al., 2017). 
Based on the promising outcomes of preclinical studies utilizing iPSCs-originated neurons 
(Kikuchi et al., 2017; Sharma et al., 2019; Tsuji et al., 2019), trials in humans are currently 
being designed for patients afflicted by Parkinson’s disease, as well as other conditions, such 




4.2 ENDOGENOUS SOURCES FOR REGENERATIVE REPAIR 
The risks associated with cell transplantation and the limited contribution of adult neural stem 
cells to widespread regeneration have encouraged research towards the discovery of alternative 
sources for safer and more efficient repair. Induction of ectopic neurogenesis in situ has been 
proposed as a novel therapeutic strategy since the realization that several differentiated cell 
types can be instructed to undertake a neuronal identity, when stimulating expression of key 
transcription factors (Chanda et al., 2014). There are fundamental advantages associated with 
strategies that aim at repurposing local cells to repopulate neural circuitries, including the vast 
availability of these cells in situ and the lack of risks associated with graft rejection. However, 
more research is needed in this field to achieve efficient lineage conversion and to demonstrate 
that newly generated neurons are molecularly and functionally comparable to the cells they aim 
to replace. Several studies have provided evidence that direct reprogramming through ectopic 
expression of transcription factors implicated in development as master regulators of 
neurogenesis, can drive lineage fate conversion of brain cells into neurons. The earliest 
example of such approach was a study published by Heins and colleagues (2002), who showed 
that neocortical glia from postnatal brains can convert to neurons under Paired box 6 (Pax6) 
overexpression when cultured in vitro. Since then, numerous other studies have shown the 
possibility to generate different types of neurons using lineage-specific fate determinants, 
individually or in combination. For instance, Distal-less homeobox 2 (Dlx2) enables induction 
of GABAergic neurons from astrocytes isolated from neonatal cortex (Heinrich et al., 2011), 
whereas, ectopic activation of Neurogenin 2 (Neurog2) or Neuronal differentiation 1 
(NeuroD1) drives conversion into functional glutamatergic neurons from postnatal astrocytes, 
as well as NG2 cells, which can give rise to both deep layer pyramidal cells and GABAergic 
interneurons (Guo et al., 2014). Earlier investigations were successful at converting cells in 
vitro or in the postnatal brain, but it has been challenging to achieve the same level of efficiency 
in the adult brain, given the less permissive parenchymal environment (Gotz et al., 2016). 
Nevertheless, new efforts are demonstrating promising results and are even showing that 
reprogrammed cells can restore tissue functionality. For instance, expression of 
Ascl1/Lmx1a/NeuroD1 together with miRNA128 has proven able to convert striatal astrocytes 
into dopaminergic neurons and rescue injury-induced motor impairment in a mouse model of 
Parkinson’s disease (Rivetti di Val Cervo et al., 2017). Similarly, transcription factors 
implicated in rod cell fate specification have been co-expressed in the retina to reveal the 
neurogenic potential of Müller glia, and restore vision in a mouse model of congenital blindness 
(Yao et al., 2018). Better efficiency of direct reprogramming can also be achieved with adjunct 
strategies that aid survival of the new neurons, rather than progressively increasing the number 
of transcription factors that are being modulated. For instance, conversion rates and survival 
can be promoted in reprogrammed cells through co-expression of Bcl2 and administration of 
anti-oxidative treatment (Gascon et al., 2016), which has increased efficiency of glia-to-neuron 
conversion up to 90%.  
Research from our lab has shown that activation of regenerative programs in local glia with 
neural stem cell properties could be a valuable alternative for promoting repair (Llorens-
 
22 
Bobadilla et al., 2020; Magnusson et al., 2014; Magnusson et al., 2020; Zamboni et al., 2020). 
Notably, direct reprogramming studies have shown that alternative fates, unrelated to the 
neuronal lineage, could arise under ectopic manipulation of transcription factors (Karow et al., 
2018; Treutlein et al., 2016). For instance, Treutlein and colleagues (2016) have observed 
generation of cells from the myogenic lineage following Ascl1 overexpression in fibroblasts, 
suggesting that transcription factor modulation alone may not be sufficient to reliably induce 
the neuronal identity, but that other factors, such as epigenetic regulation, may be at play. Our 
investigations, instead, show that Rbpj-depleted astrocytes unfold a neurogenic program that is 
virtually indistinguishable from canonical neural stem cell behavior, and does not lead to the 
generation of aberrant lineage fates (Magnusson et al., 2020; Zamboni et al., 2020). 
Additionally, contrary to direct reprogramming, activation of the neurogenic program allows 
astrocytes to enter a phase of amplification, which enables generation of up to 40 neuroblasts 
from each cell (Zamboni et al., 2020). This could greatly increase the extent of neuronal 
replacement without the risk of depleting the astroglial population, making local recruitment 
of latent neural stem cells an attractive strategy for widespread regeneration. More research is, 
however, needed in this field in order to improve efficiency of recruitment, promote survival 
of the progenitors, and verify their functional integration. A recent attempt has been made in 
this context, where researchers showed that new striatal neurons derived from Rbpj-depleted 
astrocytes are electrophysiologically active and receive synaptic input from pre-existing 
neurons, effectively demonstrating functional integration (Dorst et al., 2021). The study, 
however, suggests that these cells would provide excitatory signals to the striatum (Dorst et al., 
2021), which is inconsistent with our findings proposing that new striatal neurons have a 
GABAergic interneuronal identity (Magnusson et al., 2014; Magnusson et al., 2020).  
A limiting factor for achieving effective cell replacement in the adult brain is the mode of 
administration of the therapy. Studies have demonstrated the feasibility of using small 
molecules to attain direct reprogramming of glia into neurons (Zhang et al., 2015). However, 
the lack of target specificity of pharmaceutical options will likely lead to side effects, which 
may outweigh the benefits. Furthermore, compounds need to be able to cross the blood-brain 
barrier in order to reach their target, or they must be administered directly into the brain through 
surgical intervention. Viral gene therapy is an alternative strategy that is being explored and 
has proven promising in pre-clinical and clinical settings. In particular, the use of 
adenoassociated viruses (AAVs) has been explored in humans owing to their ability to deliver 
constructs with high efficiency and without triggering extensive inflammatory reactions (Peel 
and Klein, 2000). Surprisingly, the tropism of AAVs can change in injury conditions and 
depending on the vector being delivered, which emphasizes the importance of carefully 
designed studies that verify the identity of infected cells (Wang et al., 2021). Indeed, this was 
recently brought up in a study by Wang and colleagues (2021), who discovered that local 
neurons may have been misidentified as reprogrammed cells in several published astrocyte-to-
neuron conversion studies. Current research is aimed at improving transduction specificity, so 
that only the target cells would reliably be expressing the therapeutic genes. This can be enabled 
through capsid evolution, which has improved efficiency and specificity in other tissues 
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(Tabebordbar et al., 2021), as well as the use of cell-specific genomic elements, which regulate 
expression of the transgene in the desired cell population. In this context, innovative viral 
vector design is leveraging the great diversity of enhancer sequences in neural cells (Li et al., 
2021b) to achieve expression of the transgene exclusively in specific subtypes of brain cells 
(Graybuck et al., 2021; Mich et al., 2021). Additionally, combined with recent development in 
viral vector design, advances in the CRISPR/Cas9 technology can offer versatile and effective 
strategies for gene-editing, as well as transcriptional inhibition or activation (Dahlman et al., 
2015). For instance, CRISPR/Cas9 has been implemented to force concomitant activation of 
ten endogenous neurogenic genes and one long noncoding RNA, which enabled conversion of 
dorsal midbrain astrocytes into functional neurons (Zhou et al., 2018). Furthermore, a CRISPR 
activation screen has been implemented to identify transcription factors that would promote 
neuronal fate commitment in embryonic stem cell cultures (Liu et al., 2018). This study has 
demonstrated that combined expression of specific genes facilitates conversion and reported a 
novel role for Ezh2 in inducing neuronal identity. 
Single-cell RNA-sequencing (scRNA-seq) investigations have provided us with the 
opportunity to interrogate cellular composition and developmental dynamics of complex 
tissues with unprecedented resolution (Briggs et al., 2018; La Manno et al., 2021; Zeisel et al., 
2018) and it has made it possible to portray a complete transcriptional framework of the 
neurogenic process in homeostatic conditions (Hochgerner et al., 2018) and under 
perturbations. For instance, it revealed how ischemic injury promotes recruitment of dormant 
neural stem cells through interferon-gamma signaling (Llorens-Bobadilla et al., 2015), or that  
conditional deletion of Lrp2, an important factor implicated in neural stem cell maintenance, 
dampens proliferation, globally decreases ribosomal activity, and interferes with Wnt and BMP 
signaling (Zywitza et al., 2018). Transcriptomics analysis has also been employed to fully 
characterize the reprogramming process of human pericytes overexpressing Ascl1 and Sox2, 
and to compare the molecular profile of induced neurons to that of endogenous cells (Karow et 
al., 2018). In line with the canonical neurogenic program, pericytes transit through a neural 
stem cell-like state, albeit in the absence of cell division, prior to developing a neuron-specific 
molecular phenotype. Furthermore, the researchers were able to demonstrate that 
reprogramming success depends on the source of cells targeted for neuron production, as 
distinct pericyte clusters display heterogeneous reprogramming responses. Overall, single-cell 
resolution and access to whole-transcriptome dynamics will allow us to refine our treatment 
protocols considering cell heterogeneity and the most promising temporal window for 
delivering therapeutic agents. Furthermore, since treatment strategies for potentiating 
neurogenesis are predominantly tested in pre-clinical settings, scRNA-seq analysis may help 
generating predictions on the effectiveness of treatments in humans, through direct comparison 
of shared modes of neuronal development, patterning, and integration across species (Zhu et 




5 RESEARCH AIMS 
 
Paper I – To learn the transcriptional mechanisms underlying neurogenesis by striatal 
astrocytes and to explore manipulations to recruit a greater number of astrocytes into the 
neuronal lineage fate. 
Paper II – To assess whether neurogenesis by astrocytes is retained in different regions of the 
cortex in the presence of an injury, when Notch signaling is inhibited and to compare the 
transcriptional program of neurogenic astrocytes with that of canonical neurogenic cells, to 
support the notion that parenchymal astrocytes can be considered latent neural stem cells. 
Paper III – To provide a reliable and unbiased framework to study human hippocampal 
neurogenesis with unprecedented resolution, through transcriptional profiling of neural stem 







“What functional significance can be attributed to the neuroglia? 
Unfortunately, the present state of science does not allow to answer this 
important question but through more or less rational conjectures. When facing 
this problem, the physiologist is totally disarmed for lack of methods.”  
¾ Ramón y Cajal, 1899 
 
6.1 MODELS AND TOOLS TO STUDY ASTROCYTE BIOLOGY 
It has been challenging to investigate the plethora of physiological functions astrocytes are 
responsible for in the healthy and the injured brain. Experiments that study cells in vitro have 
the advantage of being able to tease biological functions apart, as well as study processes that 
are specific to particular cell types, which can be cultured as single populations or co-cultured 
to learn about interaction between cellular communities. The original protocol for isolation and 
culture of glia, by McCarthy and deVellis (1980), leverages the fact that astrocytes bind more 
firmly than other neural cells in a dish, so that purity is achieved by washing loose cells away. 
More recently, protocols have used antibody-conjugated magnetic beads or immunopanning 
for achieving high purity cultures and developed serum-free conditions to give rise to culture 
settings that more closely resemble physiological environments (Guttenplan and Liddelow, 
2019; Li et al., 2021a). Initial discoveries of active participation of astrocytes in neuronal 
communication have been possible thanks to in vitro modelling, although recent technological 
developments have also enabled in vivo recordings of, for instance, calcium signaling which 
can now be performed even in awake, freely moving animals (Qin et al., 2020). Cultures of 
astrocytes have also permitted manipulation of human cells and recording their response to 
stressors, such as hypoxia and oxidative damage, as well as identified species-specific 
behaviors (Li et al., 2021a). Nevertheless, the importance of astrocytes is to be fully appreciated 
when the cells are immersed in their original microenvironment, in contact with neurons whose 
activity they support, as well as blood vessels and other glial cell types they interact with. In 
this sense, refinement of in vivo experimental models has advanced our understanding of the 
specific contribution of astrocytes in health and disease. For instance, transgenic models have 
provided tools to specifically label and genetically manipulate glia to investigate their roles 
through gain- and loss-of-function designs (Srinivasan et al., 2016). Cell type-specific 
expression of fluorescent reporter tags, has facilitated isolation of astrocyte populations and the 
investigation of their molecular heterogeneity across and within regions (Batiuk et al., 2020; 
Lanjakornsiripan et al., 2018), as well as in response to injury (Hasel et al., 2021). They have, 
furthermore, assisted lineage-tracing of the glial progeny (Slezak et al., 2007), which enabled 
us to demonstrate an astroglial origin of the newly generated neurons after striatal (Magnusson 
et al., 2014) and cortical injuries (Zamboni et al., 2020). 
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6.2 MODELS AND TOOLS TO STUDY ADULT NEUROGENESIS 
Adult neurogenesis has been extensively studied in mice and other model organisms, but it has 
been challenging to investigate the same processes in the human brain. Concerns around the 
limitations and technical challenges of the current detection methods are, in fact, continuing to 
be raised, while the scientific community demands rigorous studies to validate and extend the 
methods at our disposal for identifying cellular and molecular mechanisms of neurogenesis 
(Kempermann et al., 2018; Lucassen et al., 2020). Incorporation of thymidine analogs in cells 
that had divided in adulthood has provided the first line of evidence supporting a lifelong 
addition of cells in the hippocampus (Eriksson et al., 1998). Subsequent detection of BrdU with 
immunostaning and its colocalization with neuron-specific markers has become the gold-
standard to prove the existence of adult-born neurons in the human hippocampus and striatum 
(Ernst et al., 2014; Kuhn and Cooper-Kuhn, 2007), and has been validated with independent 
measurements, such as C14-based birth dating (Spalding et al., 2013). Neurogenesis, however, 
comprises a complex cascade of cellular and molecular events, which are continuously being 
unveiled, thanks to the incessant development of technologies to track and influence generation 
and maturation of neurons. Immunostaining studies have provided information regarding the 
expression proteins at specific stages along the neurogenic trajectory (Knoth et al., 2010), 
which have also facilitated creation of transgenic lines and viral vectors that can be used for 
visualizing neural stem and progenitor cells and manipulating their function (Kuhn et al., 2018). 
The use of postmortem tissue for immunostaining has, however, constrained appreciation of 
the dynamic processes that lead to the generation of new neurons. Consequently, the 
development of novel technologies that allow in vivo, multiphoton imaging of hippocampal 
neurogenesis, has enabled researchers to uncover details on neural plasticity, progenitors’ 
survival, and fate choices, that would have been difficult to estimate in fixed postmortem 
samples (Danielson et al., 2017; Goncalves et al., 2016a; Pilz et al., 2018). Furthermore, the 
establishment of lineage tracing techniques has revolutionized our understanding of fate 
commitment and development, particularly when these techniques are combined with 
multiomics analysis (Ratz et al., 2021; Weinreb et al., 2020). In model organisms, lineage-
tracing relies on engineered genetic tags that label cells and their progeny, such as constitutive 
expression of fluorescent reporters, integration of barcode libraries, and performing heritable 
genetic scars (Kester and van Oudenaarden, 2018; Wagner and Klein, 2020), all of which have 
helped us reconstruct lineage trees for developing organisms or stem cell niches (Weinreb et 
al., 2020). Lineage tracing in humans, on the other hand, exploits naturally occurring somatic 
mutations, which are propagated in the progeny of dividing cells, but absent in distantly related 
populations (Evrony et al., 2015; Hard et al., 2019). This can be achieved via whole-genome 
or targeted sequencing of specific mobile genetic elements, as well as by leveraging the high 
mutation rate of mitochondrial DNA (Ludwig et al., 2019). Single-cell transcriptomics analysis 
has, also, been performed by multiple laboratories to fully appreciate the complex molecular 
dynamics underlying neurogenesis in the subventricular zone (Llorens-Bobadilla et al., 2015; 
Zywitza et al., 2018) and dentate gyrus of mice (Hochgerner et al., 2018; Shin et al., 2015), and 
has provided a wealth of information regarding the transcriptional mechanisms implicated in 
the activation of neural stem cells, as well as their differentiation into mature neurons. These 
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investigations will be crucial to help us answer fundamental questions related to the 
heterogeneity of neural stem and progenitor cells, the molecular identifiers and functions of 
progenitors along the course of differentiation, as well as the differential vulnerability of cells 
and processes in the presence of neurological conditions. 
 
6.3 SINGLE-CELL TRANSCRIPTOMICS 
In the past decade, scRNA-seq has established itself as a groundbreaking tool that allows to 
investigate the transcriptional profile of cells at an unprecedented resolution, with the potential 
to completely revolutionize biomedical research. Since the pioneering study of Tang and 
colleagues (2009) that recorded mRNA expression in a single mouse blastomere, the field has 
progressed at an astonishing pace, and laboratories are now sampling hundreds of thousands of 
cells to characterize their behavior and composition in health and disease (Eraslan et al., 2021), 
as well as throughout development (Cao et al., 2019; La Manno et al., 2021) and across species 
(Bakken et al., 2021). Novel technological advances in the omics field are also enabling 
epigenomics profiling at the single-cell level (Buenrostro et al., 2015), as well as to determine 
transcriptional state along with its spatial organization (Stahl et al., 2016). Multiomic analysis 
is now even accessible in the same cell, for which we can record transcriptional information, 
along with genome-wide chromatin accessibility, and protein expression (Mimitou et al., 
2021). Ultimately, multidimensional genomic measurements will bring us closer to better 
understanding gene regulation and will improve our abilities to predict cellular responses to 
genetic perturbations (Dixit et al., 2016; Kamimoto et al., 2020). 
The scRNA-seq protocols rely on dissociation of tissue into single-cell suspensions and capture 
of RNA from each lysed cell, which is converted into complementary DNA (cDNA) by reverse 
transcription and PCR-amplified to obtain enough biological material for deep sequencing. 
Different chemistries have been developed for library preparation, and their use depends on the 
scientific question they are addressing. Full-length approaches, such as Smart-seq2 (Picelli et 
al., 2013; Picelli et al., 2014), can quantify specific transcript isoforms and be used to monitor 
allele-specific expression (Deng et al., 2014; Reinius et al., 2016). The scRNA-seq reactions in 
these protocols are generally performed in well-plates, are laborious and require relatively large 
volumes of reagents, which preclude carrying out affordable, large-scale experiments. Droplet-
based methods, such as Drop-seq and inDrop, produce reads that are biased towards the 5’ end, 
thus sacrificing full-length coverage, but rely on microfluidic platforms to perform the 
reactions, which grants cost-effective scaling of the experiment (Klein et al., 2015; Macosko et 
al., 2015). These approaches embed each cell in droplets before lysing, capturing mRNA 
molecules, and introducing cell-specific barcodes so that cells can be pooled and processed 
together. Furthermore, they incorporate the unique molecular identifier (UMI) technology 
(Kivioja et al., 2011), which enables estimation of absolute numbers of molecules to control 
for amplification bias during downstream analysis. Commercialization of the droplet-based 
technology by 10x Genomics has allowed popularization of high-throughput transcriptomics 
without the need of extensive technical expertise in microfluidics. Notably, the Smart-seq3 
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protocol was recently released, which combines the major advantages of each library 
preparation method, to obtain full-length coverage combined with UMI counting strategy 
(Hagemann-Jensen et al., 2020).  
Paralleling the rapid technological advances, many computational tools have been developed 
to extract relevant biological information from scRNA-seq datasets. The statistical analysis of 
single-cell experiments is fundamentally different from classic gene expression queries owing 
to the unique structure of the data. The experimental procedure does not capture all mRNA 
molecules in each cell and genes are expressed in discrete bursts (Larsson et al., 2019). This 
leads to generating sparse matrices that require pre-processing and transformation to improve 
their interpretation. These initial steps generally include filtering of low-quality cells, followed 
by normalization of sequencing depth and logarithmic transformation of the data to equalize 
variance across genes that vary widely in expression levels. Subsequently, feature selection 
allows to identify genes that fluctuate more prominently across the dataset and that are, thus, 
more likely to reveal relevant biological variation. Finally, data are scaled and centered around 
the mean to allow easier comparison of transcriptional differences across cells. Several 
approaches have also been developed to deal with technical sources of variation, such as batch 
effects, which can be regressed out using linear models or accounted for in more sophisticated 
approaches (Butler et al., 2018). Doublets are two (or more) cells that share the same cell-
specific barcode, which need to be handled to avoid misleading biological inferences. Multiple 
approaches have been designed to identify these outliers through generation of simulated 
doublets and training of machine learning algorithms to label cells in the sample based on 
similarity to the simulated data (Bernstein et al., 2020; McGinnis et al., 2019).  
Following pre-processing, data can be visualized and grouped into populations to learn about 
sample composition. Visualization approaches aim at reducing the high dimensional structure 
of transcriptomics data to fewer (generally two) dimensions that retain at best the variation in 
the data but are easier to interpret. Uniform manifold approximation and projection (UMAP) 
is one such example that has gained popularity because it scales well with increasing size of 
datasets and because it is able to better retain the global structure of transcriptional data, 
compared to its predecessors (Becht et al., 2018). Cells can then be grouped in communities 
using different clustering approaches, such as k-means algorithms, which groups 
transcriptionally similar cells under a predetermined number of equally sized clusters, or graph-
based methods, which can accurately handle clusters that vary in size, but whose performance 
heavily relies on how well transcriptional data are converted into a graph representation 
(Andrews and Hemberg, 2018). Clustering algorithms are employed to identify cell types and 
states that share transcriptional signatures, but there exists a trade-off between resolution limit 
and robustness of clustering, which may preclude identification of rare cell populations in one 
case or introduce irrelevant subdivisions of the dataset in the other. After identifying putative 




In a developing system, cells may not be synchronized but can be found in a continuum of 
states. This allows scRNA-seq experiments that sample tissues at one timepoint to reconstruct 
a continuous dynamic process and order cells along the resulting trajectory. Multiple 
algorithms have been developed to perform this ‘pseudotemporal’ ordering, which can be used 
to infer developmental transitions in simple trajectories (Bendall et al., 2014; Qiu et al., 2017; 
Trapnell et al., 2014), as well as model branching lineage trees in datasets encompassing 
common progenitors along with progeny that differentiates into distinct cell types (Cao et al., 
2019; Setty et al., 2016). This type of analysis can, thus, reveal gene expression dynamics that 
drive lineage fate specification and identify transcriptional signatures that may be implicated 
in fate decisions. Interestingly, an algorithm developed by La Manno and colleagues (2018) 
leverages knowledge of transcription kinetics to infer future gene expression based on 
proportions of unspliced and spliced mRNA molecules in each cell. This RNA velocity analysis 
allows to predict future cell states on a timescale of hours. Finally, algorithms have been 
developed to infer gene regulatory network activity based on co-expression of transcription 
factors and putative target genes with enriched transcription factor-binding motifs (Aibar et al., 
2017; Van de Sande et al., 2020). Investigation of gene regulation with this type of analysis 
can be used to better understand the mechanisms that drive cell identity, as well as make 
predictions of cell fate conversions under transcription factor perturbation (Kamimoto et al., 
2020).    
Transcriptomics analysis has proven to be a powerful tool for dissecting tissue composition 
and cellular heterogeneity, and to study gene expression dynamics in development and disease 
conditions. Technological and computational advances in the field have enabled the scientific 
community to reveal and characterize novel cell types, as well as explore their functional 
relevance. These efforts are culminating in the ambitious production and dissemination of 
informative atlases of human tissues and model organisms (Bakken et al., 2021; Network, 
2021; Osumi-Sutherland et al., 2021; Zeisel et al., 2018) that can ultimately aid better 
understanding of cellular behavior and promote the establishment of systematic, data-driven 




7 RESULTS AND DISCUSSION 
7.1 PAPER I 
7.1.1 Summary of the results 
This study builds on previous findings of the lab demonstrating that stroke pushes striatal 
astrocytes into neurogenesis, a process regulated by Notch signaling inhibition. Here, we use a 
conditional knock-out of Rbpj-K to silence Notch signaling and characterize the neurogenic 
program of striatal astrocytes using scRNA-seq technologies. 
In pseudotemporal ordering, we see that parenchymal astrocytes are located upstream of neural 
stem cells. However, once activated, Notch-depleted astrocytes closely resemble 
subventricular zone neural stem cells in the cell states and molecular dynamics they originate. 
Additionally, striatal neurogenesis resembles hippocampal neurogenesis at the earliest stages, 
but it diverges through their differentiation, likely reflecting the different neuronal cell types 
each region gives rise to. 
We analyzed astrocytes outside the striatum and show that, albeit they fail to undertake the full 
neurogenic program, they too upregulate expression of neural stem cell genes. 
Finally, we demonstrate that striatal astrocytes that are halted at the pre-division stage can be 
recruited to produce greater numbers of transit-amplifying cells and neuroblasts via 
administration of EGF.  
7.1.2 Discussion for Paper I  
The brain has poor regenerative capacity and efforts towards achieving functional recovery 
recognize the importance of replacing neurons that are lost to injury. Recruitment of 
endogenous cells with neural stem cell capabilities is an attractive strategy for replacing 
neurons and astrocytes represent a valuable source of resident cells for this purpose. 
The present study aimed at characterizing the neurogenic program of striatal astrocytes 
following inhibition of Notch signaling and demonstrated that the molecular dynamics 
delineating the astrocyte-to-neuron transition are near-identical to those seen in canonical 
neurogenesis. We further demonstrate that even astrocytes that fail to be recruited into transit-
amplifying division show activation of a neural stem cell program.  
Our data, thus, suggests that all astrocytes may have potential to generate new neurons given 
the right molecular cues. Additionally, once recruited into neurogenesis, striatal astrocytes give 
rise to the same cell types and activate largely similar molecular programs as seen in 
subventricular zone neurogenesis, further supporting our view of parenchymal astrocytes as a 




7.2 PAPER II 
7.2.1 Summary of the results 
In this study we showed that cortical astrocytes retain the potential to generate neurons. Their 
neurogenic program is activated following Notch depletion, via conditional deletion of Rbpj-
K, and when animals are subjected to a stab wound injury.  
We further demonstrate that the neurogenic potential of astrocytes is not restricted to specific 
regions of the mouse neocortex but could be revealed across distal structures, as well as among 
all cortical layers. 
We show that silencing of Notch signaling elicits a neural stem cell program in the astrocytes, 
regardless of injury. However, it is only after injury that glia undergo cell division and generate 
neuroblasts committed to mature into cortical interneurons. 
Furthermore, we suggest that the neurogenic program can unfold irrespective of reactive 
gliosis, and that it recapitulates molecular dynamics characteristics of canonical neurogenesis. 
7.2.2 Discussion for Paper II 
Our previous investigations suggested that astrocytes may be considered as a source of 
neurogenic cells to replace neurons lost to injury. Notch signaling inhibition forces striatal 
astrocytes into the neurogenic program, but the same fate is not shared by glia in other regions 
of the brain. In order to demonstrate the widespread potential of astrocytes for cell replacement 
therapies, we turned to the cortex to show that Rbpj-K depleted astrocytes can, in fact, undergo 
neurogenesis in response to injury. 
Similar to our previous findings, we confirm that Rbpj-K deletion alone results in the activation 
of a neural stem cell program in astrocytes throughout the cortical layers, whereas it is only 
after injury that cortical cells engage in transit-amplifying division.  
We demonstrate high transcriptional similarity between neurogenesis by cortical astrocytes and 
by subventricular zone stem cells and show that cortical cells are committed to generate 
GABAergic interneurons. 
The data produced in this study may represent a valuable resource to learn the mechanisms that 
drive the commitment of astrocytes to the neurogenic fate and may support identification of 
molecular cues that enhance their recruitment. This study, further, supports the idea that 
astrocytes are a precious source of latent neural stem cells. It, also, suggests that the same 
regenerative behavior is shared among glia from different cortical layers and regions, indicating 
that astrocytes may be recruited for repair following types of damage and diseases that interest 




7.3 PAPER III 
7.3.1 Summary of the results 
This manuscript aims at characterizing the molecular profile of cells across the neurogenic 
program in the human hippocampus. We profiled about 500,000 cells from childhood and adult 
dentate gyri and identified all major cell types, including neural stem and progenitor cells. 
With the childhood dataset we performed an in-depth characterization of the transition from 
neural stem cells to neurons and identified markers describing cells at each state.  
We compared juvenile human and mouse neurogenic programs and demonstrated similar 
transcriptional dynamics occurring between the two species. 
The childhood dataset served as reference for integration with the adult samples and allowed 
us to identify adult cells with a transcriptional profile resembling that of the childhood 
neurogenic cells. Following identification of adult hippocampal neurogenic cells, we 
characterized them molecularly to detect their active gene regulatory network and specific cell 
type markers. 
7.3.2 Discussion for Paper III 
Hippocampal neurogenesis is important for memory formation and mood regulation and 
alterations in the neurogenic process has been linked to psychiatric and neurodegenerative 
conditions. Studies of adult hippocampal neurogenesis has relied on model animals for 
characterizing neural stem and progenitor cells contributing to the addition of young neurons 
to the hippocampal neural circuit. The molecular characteristics of human neurogenic cells 
have instead remained elusive due to the challenges of working with human specimens. 
In this study, we leveraged the high-throughput and transcriptome-wide resolution of snRNA-
seq experiments to provide a comprehensive characterization of the molecular profile of human 
neurogenesis across cell states, as well as throughout ages. We were able to identify neural 
stem cells, dividing and postmitotic progenitors, as well as immature neurons and show 
combinations of markers that distinguish each cell state. We, further, provided a 
characterization of active gene regulatory networks across the neurogenic trajectory and 
compared childhood and adult programs in terms of numbers of cells captured and their 
molecular features. 
We also performed a cross-species comparison to assess how closely related are mouse and 
human neurogenic programs. We found good overlap of cell types between species and 
obtained collections of conserved cell type markers that reflect the overall similarity of the 
transcriptional programs undertaken by the neural stem cells in the two species. This 
investigation, thus, supports the use of mice as a valuable model organism to study adult 
neurogenesis, but also provides a resource for identifying molecular mechanisms that are 
unique to the neurogenic program in each species. 
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Ultimately, we hope that our molecular characterization of human neurogenesis will facilitate 





The work presented in this thesis aims at proposing parenchymal astrocytes as a valuable source 
of latent neural stem cells that can be recruited, given the right molecular cues, to mount a 
regenerative response after injury in the adult brain. We have shown that astrocytes from 
different brain regions retain the potential to generate new neurons in response to Notch 
signaling inhibition and traumatic injury. Once recruited, the neurogenic program of 
parenchymal glia follows remarkably similar molecular dynamics as seen in canonical 
neurogenesis. This suggests that a better understanding of the adult neural stem cell behavior 
and the mechanisms that drive their activation and neuronal specification in the germinal niches 
may help us develop therapies that promote efficient conversion of astrocytes into neurons. We 
have worked towards this end to characterize the neurogenic trajectory of human hippocampal 
neurogenesis and produced a rich compendium of transcriptional data that can be exploited to 
learn about key transcriptional signatures of the neurogenic cells. Because the brain is incapable 
of fully repairing itself after injury, treatments that aim at replacing neurons lost to injury have 
the potential to rebuild neural circuits and achieve recovery of tissue functionality that are 
otherwise difficult to attain. Future studies in this field will have to determine if the same 
molecular mechanisms implicated in canonical neurogenesis to activate quiescent stem cells 
can be utilized to unfold an astroglial neurogenic program. Furthermore, future research may 
help us determine how to effectively integrate the new neurons in pre-existing neural circuits 
to provide functional recovery. Finally, it remains to be established whether astrocytes have 
the potential to replace neurons in different disease conditions, such as in neurodegenerative 
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